Skip to main content
Year archive

AbCellera Biologics Inc. — 2023 filings

All 33 regulatory filings released by AbCellera Biologics Inc. (ABCL) in 2023, sourced directly from the official regulator.

33 Filings
2023 Period
2023 filings (33)
Filing Released Lang
FORM 4
Director's Dealing
2023-12-20 English
8-K
Regulatory Filings
2023-11-28 English
FORM 4
Director's Dealing
2023-11-27 English
FORM 4
Director's Dealing
2023-11-08 English
10-Q
Interim / Quarterly Report Q3 2023
2023-11-02 English
8-K
Regulatory Filings
2023-11-02 English
8-K
Regulatory Filings
2023-10-13 English
FORM 4
Director's Dealing
2023-09-26 English
FORM 4
Director's Dealing
2023-09-14 English
FORM 4
Director's Dealing
2023-08-25 English
FORM 4
Director's Dealing
2023-08-09 English
10-Q
Interim / Quarterly Report Q2 2023
2023-08-03 English
8-K
Regulatory Filings
2023-08-03 English
8-K
Regulatory Filings
2023-06-20 English
FORM 4 SUBMISSION
Director's Dealing
2023-05-30 English
FORM 4 SUBMISSION
Director's Dealing
2023-05-26 English
FORM 4 SUBMISSION
Director's Dealing
2023-05-26 English
8-K
Regulatory Filings
2023-05-24 English
FORM 4 SUBMISSION
Director's Dealing
2023-05-09 English
10-Q
Interim / Quarterly Report Q1 2023
2023-05-04 English
8-K
Regulatory Filings
2023-05-04 English
DEFA14A
Regulatory Filings
2023-04-28 English
DEF 14A
Proxy Solicitation & Information Statement
2023-04-28 English
ARS
Annual Report
2023-04-28 English
SC 13D/A
Major Shareholding Notification
2023-04-24 English
8-K
Regulatory Filings
2023-03-11 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-23 English
S-8
Regulatory Filings
2023-02-21 English
10-K
Annual Report FY 2022
2023-02-21 English
8-K
Regulatory Filings
2023-02-21 English
SEC SCHEDULE 13G
Major Shareholding Notification
2023-02-13 English
SC 13G/A
Major Shareholding Notification
2023-02-06 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-01-18 English